Xeris Biopharma Holdings (XERS)'s 30-day implied volatility (IV30) was 51.5% at the close on October 30, 2026, down from 65.4% the day before, against a 52-week range of 36.8% to 96.1%. Its 20-day historical volatility was 52.5%.
Data as of October 30, 2026.